BioWorld

Feb. 10, 1992

View Archived Issues

IMMUNE RESPONSE CONSIDERS COLLABORATION

Read More

TREATMENT FOR HYPOTENSIVE DIZZINESS

Read More

ONCOR UNDERWRITERS EXERCISE OPTION

Read More

CEL-SCI RAISES $14 MILLION IN OFFERING

Read More

CYGNUS PREPARES FOR MARKET

Read More

IVAX UNIT LICENSES CHEMOPROTECTIVE

Read More

IMMUNEX DOWN ON NEGATIVE COMMENTS

Read More

NEUROGEN DRUG DEAL WITH PFIZER

Read More